Asan Medical Center: Pancreatic Neoplasms trials

The registry lists 12 Pancreatic Neoplasms studies with Asan Medical Center as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 3Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersCompletedNCT07821775
• Effect of Thrombin-containing Collagen-based Hemostatic MatrixStatus unknownNCT04357483Phase 4
• Usefulness of the Artery First Approach in Pancreatic Cancer SurgeryStatus unknownNCT04136522Not applicable
• Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic CancerCompletedNCT04133155
• Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic CancerStatus unknownNCT04110769Not applicable
• Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic CancerStatus unknownNCT03665571
• The Effect of Application of TachoSil® in PancreatoduodenectomyStatus unknownNCT03269955Phase 4
• A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
• Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP MalignancyCompletedNCT02784353Not applicable
• Neoadjuvant FDR GX in Locally Advanced Pancreatic CancerCompletedNCT01268384Phase 2
• Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic CancerStatus unknownNCT00885248
• Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic CancerCompletedNCT00786006Phase 2